Reiki Effects on Bone Marrow Transplant Patients

January 19, 2023 updated by: NURSEMIN UNAL, Ankara Medipol University

The Effect of Reiki on Fatigue, Vital Signs and Engraftment in Bone Marrow Transplant Patients

The aim of the study is to examine the effect of Reiki on fatigue, vital signs, and engraftment in bone marrow transplant patients.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Cancer is a serious and chronic disease, the number of which is increasing rapidly in our country and in the world. Today, cancer accounts for 70% of all disease diagnoses and it is estimated that the number of new cancer cases will rise to 22 million in about twenty years.

Although hematopoietic stem cell transplantation is a promising treatment for remission and complete recovery in cancer patients, the symptoms after transplantation seriously affect the quality of life of individuals. In addition to psychosocial problems, patients experience serious physical problems such as suppression of the immune system and fatigue after transplantation. Energy therapies are widely used to provide general health and well-being and to reduce or relieve the symptoms of many chronic diseases. As a result of many studies on conditions such as fatigue, pain, and anxiety, it has been determined that Reiki energy has a positive effect. When we searched the literature, it was seen that there were not enough studies examining the fatigue, vital signs, and immune systems of bone marrow transplant patients.

This randomized controlled prospective study is conducted with bone marrow transplant patients between August 2022 to February 2023. The data of the study will collect using "Personal Information Form (PIF)", "Visual Analog Scale (VAS)", and "National Cancer Institute (NCI) -Common Terminology Criteria for Adverse Events (CTCAE)". Also, vital signs and laboratory findings will be recorded.

PIF, VAS, and CTCAE will be applied to the patients who meet the inclusion criteria. Patients will be randomized 1:1 into groups to the block randomization method. There are two arms in the study; Reiki (n=21) and control group (n=21). A second-degree Reiki practitioner will apply Reiki to the patients for 30 minutes. on the second day and the third day, 30 minutes distance Reiki will be applied to the patients. In the control group, nothing will be done. Post-tests will be applied to all patients after one week and vital signs and laboratory findings will be recorded.

Study Type

Interventional

Enrollment (Anticipated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • None Selected
      • Ankara, None Selected, Turkey, 06050

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being over 18 years old
  • Not having a communication problem,
  • Autologous bone marrow transplantation has been performed
  • Willingness to participate in Reiki practice,
  • To be competent to answer the data collection tools to be used in the research.
  • Not using complementary practices (energy therapies) in the last six months.

Exclusion Criteria:

  • Having a communication problem
  • Application of allogeneic bone marrow transplantation
  • Not being willing to engage in Reiki practice
  • Reiki practitioner or instructor,
  • Have received energy therapy sessions such as Reiki/Therapeutic touch/Healing touch in the last six months
  • Application of bone marrow transplantation for hematological cancers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reiki Group
Personal Information Form (PIF), Visual Analog Scale (VAS), and National Cancer Institute (NCI) -Common Terminology Criteria for Adverse Events (CTCAE) will be administered to the patients. Then vital signs and laboratory findings will be recorded. After the protests will be completed, the primary investigator with Reiki second degree will apply Reiki to the patients for 30 minutes. On the second day and the third day, 30 minutes distance Reiki will be applied to the patients. Post-tests will be applied to all patients after one week and vital signs and laboratory findings will be recorded.
Reiki has based on the belief that disease occurs when an energy center is blocked, and that the energy is transmitted through touch. In distance Reiki, Reiki practitioners followed the traditional Usui Reiki protocol healing.
No Intervention: Control Group
Personal Information Form (PIF), Visual Analog Scale (VAS), and National Cancer Institute (NCI) -Common Terminology Criteria for Adverse Events (CTCAE) will be administered to the patients. Then vital signs and laboratory findings will be recorded. After a week, the posttest will be applied to the patients and vital signs and laboratory findings will be recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal Information Form
Time Frame: Baseline
There are questions to determine the soci-demographic features and the characteristics of the disease/treatment process.
Baseline
Visual Analog Scale
Time Frame: Change from baseline Visual Analog Scale at one week
It is a reliable and easily applicable scale used to measure the severity of pain in patients, accepted in the world literature. The scale, which was used to digitize the values that could not be measured numerically, was used to evaluate the pain intensity of the patients. A minimum of 0 and a maximum of 10 points can be obtained from the scale. In addition, high scores indicate increased pain intensity.
Change from baseline Visual Analog Scale at one week
Fatigue
Time Frame: Change from fatigue level at a week
Common Terminology Criteria for Adverse Events (CTCAE) define adverse events experienced by cancer patients. Patients are asked to number the level of fatigue from 0 to 10. As the score increases, the severity of fatigue also increases.
Change from fatigue level at a week
Engraftment
Time Frame: After one week
Engraftment is when the transplanted stem cells grow and produce new blood cells at levels that can be counted in the bloodstream.
After one week
Change from Leukocyte values at a week
Time Frame: Change from Leukocyte values at a week
They are the leading elements of the body's defense system.
Change from Leukocyte values at a week
Change from Hemoglobin values at a week
Time Frame: Change from Hemoglobin values at a week
Hemoglobin is a substance found in red blood cells that makes it possible for the blood to carry oxygen throughout the body.
Change from Hemoglobin values at a week
Change from Hematocrit values at a week
Time Frame: Change from Hematocrit values at a week
Hematocrit refers to the ratio of the volume of red blood cells to the amount of circulating blood.
Change from Hematocrit values at a week
Change from Erythrocyte values at a week
Time Frame: Change from Erythrocyte values at a week
The erythrocyte contains hemoglobin, which is involved in the transport of oxygen in the body.
Change from Erythrocyte values at a week
Change from heart rate values at a week
Time Frame: Change from heart rate values at a week
The number of times the heart beats per minute is the heart rate.
Change from heart rate values at a week
Change from systolic and diastolic blood pressure values at a week
Time Frame: Change from systolic and diastolic blood pressure values at a week
Blood pressure is the pressure of the blood within the arteries of the circulatory system.
Change from systolic and diastolic blood pressure values at a week
Change from body temperature values at a week
Time Frame: Change from body temperature values at a week
Body temperature indicates the balance between the heat produced in the body and the heat consumed. A certain temperature is needed for the human body to continue its functions.
Change from body temperature values at a week
Change from respiratory rate values at a week
Time Frame: Change from respiratory rate values at a week
At rest, the respiratory rate of an adult should be 12-20/min.
Change from respiratory rate values at a week
Change from oxygen saturation values at a week
Time Frame: Change from oxygen saturation values at a week
Oxygen saturation refers to the oxygen saturation in the blood.
Change from oxygen saturation values at a week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nilay BEKTAS AKPINAR, Ankara Medipol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Anticipated)

February 28, 2023

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

January 7, 2023

First Submitted That Met QC Criteria

January 19, 2023

First Posted (Actual)

January 23, 2023

Study Record Updates

Last Update Posted (Actual)

January 23, 2023

Last Update Submitted That Met QC Criteria

January 19, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 113 (Other Identifier: Shenzhen Universisty general hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Reiki

Subscribe